Literature DB >> 25240467

Animals are key to human toxoplasmosis.

Dirk Schlüter1, Walter Däubener2, Gereon Schares3, Uwe Groß4, Uwe Pleyer5, Carsten Lüder4.   

Abstract

Toxoplasma gondii is an extremely sucessfull protozoal parasite which infects almost all mamalian species including humans. Approximately 30% of the human population worldwide is chronically infected with T. gondii. In general, human infection is asymptomatic but the parasite may induce severe disease in fetuses and immunocompromised patients. In addition, T. gondii may cause sight-threatening posterior uveitis in immunocompetent patients. Apart from few exceptions, humans acquire T. gondii from animals. Both, the oral uptake of T. gondii oocysts released by specific hosts, i.e. felidae, and of cysts persisting in muscle cells of animals result in human toxoplasmosis. In the present review, we discuss recent new data on the cell biology of T. gondii and parasite diversity in animals. In addition, we focus on the impact of these various parasite strains and their different virulence on the clinical outcome of human congenital toxoplasmosis and T. gondii uveitis.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Congenital toxoplasmosis; Epidemiology; Toxoplasma; Toxoplasma eye infection; Zoonotic infection

Mesh:

Year:  2014        PMID: 25240467     DOI: 10.1016/j.ijmm.2014.09.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  50 in total

Review 1.  Toxoplasmosis in Germany.

Authors:  Uwe Pleyer; Uwe Gross; Dirk Schlüter; Henrik Wilking; Frank Seeber
Journal:  Dtsch Arztebl Int       Date:  2019-06-21       Impact factor: 5.594

Review 2.  Genomics of apicomplexan parasites.

Authors:  Lakshmipuram Seshadri Swapna; John Parkinson
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-02-22       Impact factor: 8.250

3.  Comparisons of Toxoplasma gondii Prevalence in Rural and Urban Areas of Al-Najaf Province of Iraq Using Serological Methods.

Authors:  K Abdul Ameer Jaber; R Aamer Noori
Journal:  Arch Razi Inst       Date:  2021-12-30

4.  Toxoplasma gondii infection in slaughtered domestic ruminants in Northwest Ethiopia: occurrence, bioassay and virulence assessment.

Authors:  Moges Maru; Debasu Damtie; Ambaye Kenubih; Abiy Maru; Biyansa Adugna; Shimelis Dagnachew; Zewdu Seyoum Tarekegn
Journal:  J Parasit Dis       Date:  2022-01-22

5.  Cerebral toxoplasmosis in a cat with feline leukemia and feline infectious peritonitis viral infections.

Authors:  Luca Zandonà; Romina Brunetta; Claudia Zanardello; Marta Vascellari; Luca Persico; Elena Mazzolini
Journal:  Can Vet J       Date:  2018-08       Impact factor: 1.008

6.  Seroepidemiology and risk factors of Toxoplasma gondii infection in undergraduate university female students in Jordan.

Authors:  M M Obaidat; N A Al-Sheyab; A E Bani Salman; S Q Lafi
Journal:  Epidemiol Infect       Date:  2014-12-29       Impact factor: 4.434

7.  Calomys callosus chronically infected by Toxoplasma gondii clonal type II strain and reinfected by Brazilian strains is not able to prevent vertical transmission.

Authors:  Priscila S Franco; Neide M da Silva; Bellisa de Freitas Barbosa; Angelica de Oliveira Gomes; Francesca Ietta; E K Shwab; Chunlei Su; José R Mineo; Eloisa A V Ferro
Journal:  Front Microbiol       Date:  2015-03-10       Impact factor: 5.640

8.  Toxoplasma gondii Pneumonia in an Immunocompetent Individual.

Authors:  Chang-xing Shen; Guo-liang Zhang; Xiao-lian Song; Shuan-shuan Xie; Chang-hui Wang
Journal:  Am J Med Sci       Date:  2015-07       Impact factor: 2.378

9.  Sequence Diversity in MIC6 Gene among Toxoplasma gondii Isolates from Different Hosts and Geographical Locations.

Authors:  Zhong-Yuan Li; Hui-Qun Song; Jia Chen; Xing-Quan Zhu
Journal:  Korean J Parasitol       Date:  2015-06-30       Impact factor: 1.341

Review 10.  Oxidative Stress as a Possible Target in the Treatment of Toxoplasmosis: Perspectives and Ambiguities.

Authors:  Karolina Szewczyk-Golec; Marta Pawłowska; Roland Wesołowski; Marcin Wróblewski; Celestyna Mila-Kierzenkowska
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.